SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-024121
Filing Date
2021-05-03
Accepted
2021-05-03 09:00:22
Documents
17
Period of Report
2021-05-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea140205-8k_aikidopharma.htm 8-K 17490
2 PRESENTATION, DATED MAY 3, 2021 ea140205ex99-1_aikidopharma.htm EX-99.1 23144
3 GRAPHIC ex99-1_001.jpg GRAPHIC 75142
4 GRAPHIC ex99-1_002.jpg GRAPHIC 167695
5 GRAPHIC ex99-1_003.jpg GRAPHIC 183015
6 GRAPHIC ex99-1_004.jpg GRAPHIC 232925
7 GRAPHIC ex99-1_005.jpg GRAPHIC 201515
8 GRAPHIC ex99-1_006.jpg GRAPHIC 170727
9 GRAPHIC ex99-1_007.jpg GRAPHIC 241471
10 GRAPHIC ex99-1_008.jpg GRAPHIC 148269
11 GRAPHIC ex99-1_009.jpg GRAPHIC 224750
12 GRAPHIC ex99-1_010.jpg GRAPHIC 212496
13 GRAPHIC ex99-1_011.jpg GRAPHIC 191384
14 GRAPHIC ex99-1_012.jpg GRAPHIC 216396
15 GRAPHIC ex99-1_013.jpg GRAPHIC 143953
16 GRAPHIC ex99-1_014.jpg GRAPHIC 214314
17 GRAPHIC ex99-1_015.jpg GRAPHIC 72191
  Complete submission text file 0001213900-21-024121.txt   3756582
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 21881605
SIC: 8731 Services-Commercial Physical & Biological Research